Saif, Muhammad Wasif <br/><br/>
Docetaxel second-line therapy in patients with advanced pancreatic cancer: a retrospective study.  [electronic resource] 

 -  Anticancer research  Jul 2010 
 - 2905-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-7530 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--blood<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>CA-19-9 Antigen--blood<br/>Capecitabine<br/>Deoxycytidine--administration & dosage<br/>Docetaxel<br/>Erlotinib Hydrochloride<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Pancreatic Neoplasms--blood<br/>Quality of Life<br/>Quinazolines--administration & dosage<br/>Retrospective Studies<br/>Salvage Therapy<br/>Taxoids--administration & dosage<br/>Gemcitabine